Company & Sponsor Intelligence

University of Maryland, College Park

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials3
Recruiting0
Completed3
Countries1

Therapeutic footprint

adhdepilepsy

Indexed studies

NCT01065597Nonconvulsive Electrotherapy: a Proof-of-concept Trial
epilepsy · United States
PHASE1
NCT00316290Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder
adhd · United States
NA
NCT00318981Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
adhd · United States
PHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →